InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Hall Justin, Chief Executive Officer. Officer active across 1 companies, notably NovaBay Pharmaceuticals, Inc.. Cumulatively, 2 filings have been published. Total volume traded: €53k. The latest transaction was filed on 6 December 2021 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€26,53769,767 shares@ €0.38040.051% mcap100.0% of flow
Common Stock
SEC:0001437749-21-027958·
Ideal exit: 2 Sept 2022 (T+270)
€26,53769,767 shares@ €0.38040.051% mcap50.0% of flow
Common Stock
SEC:0001437749-21-027958:0·
Ideal exit: 2 Sept 2022 (T+270)
2 of 2 declarations
About Hall Justin
Justin Hall is the CEO, General Counsel, and Director of NovaBay Pharmaceuticals, Inc. He oversees the company's operations and ensures legal compliance. His role is essential for the company's strategy and risk management.
